PLRX (Pliant Therapeutics) FFO


PLRX Pliant Therapeutics Inc PLRX
31 GF Score
Price $1.14
! 2 Warning Signs
View Full Analysis

What is Pliant Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

PLRX
31GF Score
Pliant Therapeutics Inc PLRX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pliant Therapeutics Business Description

Other Exchanges 9PT:Germany
Address 331 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
31GF Score

Get the complete analysis for PLRX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.14
Price